ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Synapse Biomedical Receives FDA Emergency Use Authorization for New System to Assist in Weaning Patients off of Ventilators During COVID-19 Pandemic prnasia
April 15, 2020Synapse Biomedical, Inc. has received FDA Emergency Use Authorization for the emergency use of its TransAeris? DPS, to assist in weaning patients determined by their healthcare provider to be at high risk of weaning failure off of ventilators in healthcar
Pharma Sources Insight January 2025
